Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Type I interferon receptor 1 MAb evaluated in patients with scleroderma

Dec. 7, 2012

New MMP-13 inhibitors divulged by Abbott Laboratories

Dec. 5, 2012

A new murine model for the study of acute inflammatory arthritis

Dec. 5, 2012

Wellstat Immuno Therapeutics prepares new polypeptides

Dec. 5, 2012

Horizon Pharma launches novel prednisone formulation in the U.S.

Dec. 4, 2012

Galapagos opens GLPG-0634 IND in the U.S.

Dec. 4, 2012

Clinical program commences for reformulated muscle relaxant Metaxalone SoluMatrix

Dec. 4, 2012

Protalex treats first patient phase Ib PRTX-100 trial

Nov. 30, 2012

RVX-297 reduces clinical signs of disease in a rat model of rheumatoid arthritis

Nov. 30, 2012

Murdoch Childrens opens Australian site in global study of BioMarin's achondroplasia treatment

Nov. 26, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...